Intraoperative adverse events
Conditions
Interventions
Control group:spinal anesthesia alone
Experimental group 1:spinal anesthesia and buccal acupuncture therapy, including bilateral Triple Energizer (TE) point and cervical points
Experimental group 2:spinal anesthesia and buccal acupuncture therapy, including bilateral Triple Energizer (TE) point and dorsal points
Experimental group 3:spinal anesthesia and buccal acupuncture therapy, including bilateral Triple Energizer (TE) point and lumbar points
Sponsors
Affiliated Hospital of North Sichuan Medical College
Eligibility
Sex/Gender
Female
Age
23 Years to 30 Years
Inclusion criteria
Inclusion criteria: 1.Postpartum women aged 23-30 who have undergone cesarean section; 2.Pregnancy weeks are 37-41 weeks, parity <=2, and parity <= 3; 3.No history of adverse pregnancy and childbirth, no pregnancy complications; 4.The American Society of Anesthesiologists (ASA) classifies physical condition into grades I-II; 5.Having systematic prenatal care and no underlying diseases; 6.Voluntarily participate in this research project and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients and their families patient refuse to participate in the study 2.Patients with abnormal coagulation function 3.Patients with infected or ulcerated skin at the acupuncture site 4.Patients with a history of chronic pain or continuous use of analgesics within 2 weeks before surgery 5.Patients with previous drug abuse or alcohol dependence 6.Patients who experience major bleeding or serious complications during surgery, or who need to be transferred to the intensive care unit for treatment after surgery 7.Patients with psychiatric disorders, communication barriers, or taking psychiatric medications within the past 6 months. 8.Severe allergy to ropivacaine and other local anesthetic drugs 9. The responsible surgeon determines that the patient is unsuitable or poses medical risks for participation in the trial based on clinical assessment and judgment 10.Patients requiring conversion to general anesthesia or rescue intravenous sedation/analgesia/antiemetic medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chest discomfort(Y/N);shortness of breath(Y/N);Numerical score of Nauseavisual analog scale;Vomiting(Y/N); | — |
Secondary
| Measure | Time frame |
|---|---|
| Numerical score of Visual Analogue Scale;Tropisetron consumption during operation;Oxycodone consumption during operation;Times of perioperative antiemetics applied;Time of first perioperative application of antiemetics;Exhaustion (Y/N);Postoperative nausea and vomiting (Y/N);Basal heart rate\blood pressure\SpO2;heart rate\blood pressure\SpO2;heart rate\blood pressure\SpO2;the levels of CRP;the levels of IL-6 and IL-10;the level of TNF-a;shivering(Y/N);the levels of prostaglandins; | — |
Countries
China
Contacts
Public ContactJingyan Lin
Affiliated Hospital of North Sichuan Medical College
Outcome results
None listed